Press Release from NCI: NCI study advances personalized immunotherapy for metastatic breast cancer

The latest press release from the National Cancer Institute

Having trouble viewing this email? View it as a Web page.

You are subscribed to Press Releases from the National Cancer Institute. New press releases are listed below.     NCI study advances personalized immunotherapy for metastatic breast cancer 02/01/2022 NCI researchers have shown that an experimental form of immunotherapy that uses an individual's own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer who have exhausted all other treatment options.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892